EUVIMEDEUVIMED entdecken
Crossref

CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation

Liqiang Qi iD, Bo Sun, Beibei Yang, Su Lu

Human Molecular Genetics · 18.05.2023 · 32 (11) · 1850-1863

DOI: 10.1093/hmg/ddad022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 02.02.2023. Verfasst von Liqiang Qi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgical Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, B…. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (bc) is the second most common type of human malignancies with highest morbidity and mortality in the female population. Therefore, it is essential to develop novel and effective therapies for bc treatment. The main aim of the current study is to investigate the functions of CEBPB and THBS2 in bc and the underlying mechanism. Reverse transcription–quantitative real-time polymerase chain reaction and western blot were performed for the measurement of ribonucleic acids and proteins. Function and mechanism assays were, respectively, conducted for the evaluation of bc biological behaviors and exploration of the potential correlation of genes. According to bioinformatics analyses and experimental results, THBS2, up-regulated in bc tissues and cell lines, could facilitate cell migration, invasion and EMT in bc. CEBPB was validated to facilitate miR-29a-3p transcription, thus negatively modulating THBS2 expression. The results of rescue experiments reflected that CEBPB could regulate the malignant behaviors of bc cells via THBS2. Furthermore, CEBPB was ascertained to inhibit the transcription of B3GALTL to affect THBS2 protein O-fucosylation and secretion. The interaction between THBS2 and ITGB1 was confirmed, and THBS2 was found to activate the PI3K/AKT signaling pathway. To conclude, CEBPB could restrain bc cell migration, invasion and EMT via inhibition on THBS2 expression and O-fucosylation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsHumansFemalePhosphatidylinositol 3-KinasesSignal TransductionCell LineCell MovementCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticCCAAT-Enhancer-Binding Protein-beta

Substanzen

MicroRNAsPhosphatidylinositol 3-KinasesCEBPB protein, humanCCAAT-Enhancer-Binding Protein-beta

Autor:innen und Institutionen

  • Department of Breast Surgical Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • The 2nd Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.

ORCID-Profile: Liqiang Qi

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Qi, L., Sun, B., Yang, B., & Lu, S. (2023). CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation. Human Molecular Genetics, 32(11), 1850-1863. https://doi.org/10.1093/hmg/ddad022

Vancouver

Qi L, Sun B, Yang B, Lu S. CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation. Human Molecular Genetics. 2023;32(11):1850-1863. doi:10.1093/hmg/ddad022

BibTeX
@article{Qi2023,
  author = {Qi, Liqiang and Sun, Bo and Yang, Beibei and Lu, Su},
  title = {CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation},
  journal = {Human Molecular Genetics},
  year = {2023},
  volume = {32},
  number = {11},
  pages = {1850--1863},
  doi = {10.1093/hmg/ddad022}
}
Kostenlos starten →